Subject
Neurology (clinical),Neurology,General Medicine
Reference28 articles.
1. Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years;Auer;Sci. Rep.,2021
2. Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort;Bigaut;Mult. Scler. J.,2021
3. Initial high-efficacy disease-modifying therapy in multiple sclerosis;Buron;Neurology,2020
4. Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP);Butzkueven;J. Neurol. Neurosurg. Psychiatry,2020
5. Danish Medicines Council, 2021. Behandlingsvejledning og lægemiddelrekommendation vedrørende lægemidler til attakvis multipel sklerose [WWW Document]. URL https://medicinraadet.dk/media/h0bdeq5z/medicinrådets_lægemiddelrekom-_og_behandlingsvejl-_vedr-_attakvis_multipel_sklerose-vers-_1-4_adlegacy.pdf.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献